FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Int J Rheum Dis / Diagnosis of Kawasaki disease.
International journal of rheumatic diseases2017; 21(1); 36-44; doi: 10.1111/1756-185X.13224

Diagnosis of Kawasaki disease.

Abstract: Kawasaki disease (KD) is a medium vessel vasculitis with predilection for coronary arteries. Due to lack of a reliable confirmatory laboratory test, the diagnosis of KD is based on a constellation of clinical findings that appear in a typical temporal sequence. These diagnostic criteria have been modified from time to time and the most recent guidelines have been proposed by the American Heart Association (AHA) in 2017. However, several children may have incomplete or atypical forms of KD and the diagnosis can often be difficult, especially in infants and young children. In this review, we have detailed the steps involved in arriving at a diagnosis of KD and also highlight the important role of echocardiography in diagnosis and management of children with KD.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Get Full Text
Publication Date: 2017-11-13 PubMed ID: 29131549PubMed Central: PMC7159575DOI: 10.1111/1756-185X.13224Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study revolves around the investigation of the causes of Kawasaki disease by conducting serological testing on children suffering from the disease and an examination of potential links to certain viral antibodies and cytotoxins.

Objective of the Research

  • The main goal of the study was to explore the etiology, or causes, of Kawasaki disease. This was executed by checking patient serum samples for antibodies associated with four specific viruses and for cytotoxic properties, potentially linked to the cytotoxin produced by a type of bacteria, Propionibacterium acnes.

Research Methodology

  • The researchers obtained 13 serum samples from nine children who had been diagnosed with Kawasaki disease.
  • They also accumulated 23 control samples for comparative analysis. The control samples are typically taken from individuals who do not have the disease being studied to set a baseline for comparison.
  • These samples were screened for the presence of antibodies to four viruses – hog cholera virus, border disease of sheep, bovine diarrhoea virus, and equine arteritis virus.

Results of the Study

  • The serum samples, both from children with Kawasaki disease and the control samples, did not exhibit antibodies for the four viruses that were screened.
  • They, therefore, concluded that there is no direct relationship between these viruses and the occurrence of Kawasaki disease.
  • However, serum samples from two children with Kawasaki disease showed cytotoxic properties. Cytotoxicity refers to a substance’s capacity to be harmful or lethal to certain cells.

Implications of the Study

  • The observed cytotoxicity led them to further consider a possible link with a cytotoxin from Propionibacterium acnes – a common type of bacteria that can produce such cytotoxic substances.
  • If confirmed, such a link could suggest a bacterial role in the etiology of Kawasaki disease.
  • This implies a new avenue of further research to explore this potential link, which may result in an improved understanding of Kawasaki disease and therefore better strategies for its treatment or prevention.

Cite This Article

APA
Singh S, Jindal AK, Pilania RK. (2017). Diagnosis of Kawasaki disease. Int J Rheum Dis, 21(1), 36-44. https://doi.org/10.1111/1756-185X.13224

Publication

International journal of rheumatic diseases
ISSN: 1756-185X
NlmUniqueID: 101474930
Country: England
Language: English
Volume: 21
Issue: 1
Pages: 36-44

Researcher Affiliations

Singh, Surjit
  • Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post-Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Jindal, Ankur Kumar
  • Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post-Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Pilania, Rakesh Kumar
  • Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post-Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

MeSH Terms

  • Age of Onset
  • Algorithms
  • Biomarkers / blood
  • Child
  • Child, Preschool
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / pathology
  • Decision Support Techniques
  • Developing Countries
  • Echocardiography
  • Humans
  • Infant
  • Mucocutaneous Lymph Node Syndrome / blood
  • Mucocutaneous Lymph Node Syndrome / complications
  • Mucocutaneous Lymph Node Syndrome / diagnostic imaging
  • Mucocutaneous Lymph Node Syndrome / pathology
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors

Conflict of Interest Statement

None.

References

This article includes 70 references
  1. Newburger JW, Takahashi M, Gerber MA. Diagnosis, treatment, and long‐term management of Kawasaki disease: a statement for health professionals from the committee on Rheumatic fever, Endocarditis and Kawasaki disease, council on Cardiovascular disease in the young. Circulation 110, 2747–71.
    pubmed: 15505111
  2. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi Allergy 16, 178–222.
    pubmed: 6062087
  3. Ayusawa M, Sonobe T, Uemura S. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47 (2), 232–4.
    pubmed: 15771703
  4. McCrindle BW, Rowley AH, Newburger JW. Diagnosis, treatment, and long‐term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation 135, e927–99.
    pubmed: 28356445
  5. Yoshino A, Tanaka R, Takano T, Oishi T. Afebrile Kawasaki disease with coronary artery dilatation. Pediatr Int 59, 375–7.
    pubmed: 28317308
  6. Kushner HI, Macnee R, Burns JC. Impressions of Kawasaki syndrome in India. Indian Pediatr 43, 939–42.
    pubmed: 17151396
  7. Chao SM, Phua KB. Perineal eruption as an early sign of Kawasaki disease. Ann Acad Med Singapore 20 (2), 244–7.
    pubmed: 1883184
  8. Saguil A, Fargo M, Grogan S. Diagnosis and management of Kawasaki disease. Am Fam Physician 91, 365–71.
    pubmed: 25822554
  9. Burns JC, Mason WH, Glode MP. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki disease study group. J Pediatr 118, 680–6.
    pubmed: 2019921
  10. Kim GB, Han JW, Park YW. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009–2011. Pediatr Infect Dis J 33 (1), 24–7.
    pubmed: 24064559
  11. Sung RYT, Ng Y‐M, Choi K‐C. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease. Pediatr Infect Dis J 25, 521–5.
    pubmed: 16732150
  12. Nozaki T, Morita Y, Hasegawa D. Cervical ultrasound and computed tomography of Kawasaki disease: comparison with lymphadenitis. Pediatr Int 58, 1146–52.
    pubmed: 27097838
  13. Cai Q, Luo R, Gan J, Zhang L, Qu Y, Mu D. Kawasaki disease mimicking a parapharyngeal abscess: a case report. Medicine (Baltimore) 94, e761.
    pmc: PMC4603063pubmed: 25929913
  14. Singh S, Sharma A, Jiao F. Kawasaki disease: issues in diagnosis and treatment–a developing country perspective. Indian J Pediatr 83 (2), 140–5.
    pubmed: 26400032
  15. Kumar R, Indira K, Rizvi A, Rizvi T, Jeyaseelan L. Antibiotic prescribing practices in primary and secondary health care facilities in Uttar Pradesh. India. J Clin Pharm Ther 33, 625–34.
    pubmed: 19138240
  16. Basu S, Chatterjee M, Chandra PK, Basu S. Antibiotic misuse in children by the primary care physicians–an Indian experience. Niger J Clin Pract 11 (1), 52–7.
    pubmed: 18689140
  17. Zhang Z, Zhan X, Zhou H. Antibiotic prescribing of village doctors for children under 15 years with upper respiratory tract infections in rural China: a qualitative study. Medicine (Baltimore) 95, e3803.
    pmc: PMC4907660pubmed: 27281082
  18. Tan YC. Rash and fever in a 3‐year‐old girl. Ann Allergy Asthma Immunol 76 (1), 16–8.
    pubmed: 8564623
  19. Bhat M. Kawasaki disease in Jammu and Kashmir. Indian Pediatr 53, 438.
    pubmed: 27254065
  20. Singh S, Kawasaki T. Kawasaki disease in India, lessons learnt over the last 20 years. Indian Pediatr 53 (2), 119–24.
    pubmed: 26897142
  21. Kumar A, Singh S. BCG site reactivation in Kawasaki disease. Arthritis Rheumatol (Hoboken) 68, 2026.
    pubmed: 27059401
  22. Garrido‐García LM, Castillo‐Moguel A, Vázquez‐Rivera M, Cravioto P, Fernando G. Reaction of the BCG scar in the acute phase of Kawasaki disease in Mexican children. Pediatr Infect Dis J 36, e234–41.
    pubmed: 28498302
  23. Watanabe T. Pyuria in patients with Kawasaki disease. World J Clin Pediatr 4 (2), 25–9.
    pmc: PMC4438438pubmed: 26015877
  24. Álvarez EP, Rey F, Peña SC, Rubio A, Calvo C, Collado P. Has joint involvement lessened in Kawasaki disease?. Reumatol Clin 13, 145–9.
    pubmed: 27263965
  25. Mathai SS, Kulkarni VB, Harsh P. Gall bladder hydrops ‐ a rare initial presentation of Kawasaki disease. Indian J Pediatr 80, 616–7.
    pubmed: 23180399
  26. Dahdah N. Not just coronary arteritis, Kawasaki disease is a myocarditis, too. J Am Coll Cardiol 55, 1507; author reply 1507–8.
    pubmed: 20359606
  27. Singh S, Agarwal S, Bhattad S. Kawasaki disease in infants below 6 months: a clinical conundrum?. Int J Rheum Dis 19, 924–8.
    pubmed: 26990891
  28. Salgado AP, Ashouri N, Berry EK. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr 185, 112–6.
    pmc: PMC5529235pubmed: 28408126
  29. Cai Z, Zuo R, Liu Y. Characteristics of Kawasaki disease in older children. Clin Pediatr (Phila) 50, 952–6.
    pubmed: 21628347
  30. Bresson V, Bonello B, Rousset‐Rouvière C. Kawasaki disease in older children and young adults: 10 years of experience in Marseille, France. Arch Pediatr 18, 731–6.
    pubmed: 21600744
  31. Lloyd AJ, Walker C, Wilkinso M. Kawasaki disease: is it caused by an infectious agent?. Br J Biomed Sci 58 (2), 122–8.
    pubmed: 11440204
  32. Rowley AH. Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med 62, 69–77.
    pmc: PMC3021097pubmed: 20690826
  33. Rowley AH. Can a systems biology approach unlock the mysteries of Kawasaki disease?. Wiley Interdiscip Rev Syst Biol Med 5 (2), 221–9.
    pubmed: 23293016
  34. Turnier JL, Anderson MS, Heizer HR, Jone P‐N, Glodé MP, Dominguez SR. Concurrent respiratory viruses and Kawasaki disease. Pediatrics 136, e609–14.
    pubmed: 26304824
  35. Fukuda S, Ito S, Fujiwara M. Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: a case report. Pediatr Rheumatol Online J 15 (1), 39.
    pmc: PMC5432973pubmed: 28511718
  36. Hu P, Guan Y, Fan XC, Lu FY, Song LM. Incomplete Kawasaki disease induced by measles in a 6‐month‐old male infant. Int J Dermatol 55 (1), e34–36.
    pubmed: 26518488
  37. Chang L‐Y, Lu C‐Y, Shao P‐L. Viral infections associated with Kawasaki disease. J Formos Med Assoc Taiwan Yi Zhi 113, 148–54.
    pmc: PMC7125523pubmed: 24495555
  38. Agarwal E, Shah D, Gupta P. Dengue fever triggering Kawasaki disease. Indian Pediatr 54 (1), 51–2.
    pubmed: 28141566
  39. Singh S, Jat KR, Suri D, Ratho RK. Dengue fever and Kawasaki disease: a clinical dilemma. Rheumatol Int 29, 717–9.
    pubmed: 19030863
  40. Singh SP, Ansari NH, Tanwar YS, Habib M. Osteomyelitis in Kawasaki disease. Indian J Pediatr 81, 1384–6.
    pubmed: 24788915
  41. Matsubara K, Fukaya T. The role of superantigens of group a Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis 20, 298–303.
    pubmed: 17471041
  42. Leahy TR, Cohen E, Allen UD. Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: a case report. Can J Infect Dis Med Microbiol J Can Mal Infect Microbiol Medicale 23, 137–9.
    pmc: PMC3476559pubmed: 23997782
  43. Hamada H, Sekizuka T, Oba K. Comprehensive pathogen detection associated with four recurrent episodes of Kawasaki disease in a patient during a single year using next‐generation sequencing. JMM Case Rep 3 (1), e005019.
    pmc: PMC5343132pubmed: 28348750
  44. Lee MN, Cha JH, Ahn HM. Mycoplasma pneumoniae infection in patients with Kawasaki disease. Korean J Pediatr 54, 123–7.
    pmc: PMC3120998pubmed: 21738542
  45. Vaidya PC, Narayanan K, Suri D. Pulmonary presentation of Kawasaki disease: an unusual occurrence. Int J Rheum Dis [in press] .
    doi: 10.1111/1756-185X.12815pubmed: 26662672google scholar: lookup
  46. Bonany PJ, Bilkis MD, Gallo G. Acute renal failure in typical Kawasaki disease. Pediatr Nephrol Berl Ger 17, 329–31.
    pubmed: 12042888
  47. Chuang G‐T, Tsai I‐J, Lin M‐T, Chang L‐Y. Acute kidney injury in patients with Kawasaki disease. Pediatr Res 80 (2), 224–7.
    pubmed: 27064240
  48. Choi HS, Lee SB, Kwon JH, Kim HS, Sohn S, Hong YM. Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease. Korean J Pediatr 58, 374–9.
    pmc: PMC4644765pubmed: 26576181
  49. Madhusudan S, Singh S, Suri D, Gupta A, Gupta A. Acute anterior uveitis as the presenting feature of Kawasaki disease. Indian J Pediatr 81, 415.
    pubmed: 24562721
  50. Agarwal S, Mulkutkar S, Suri D, Singh S, Gupta A. Retinal vasculitis in Kawasaki disease. Indian J Pediatr 82, 1183–4.
    pubmed: 25990595
  51. Dhawan SR, Vaidya PC, Suri D, Singh S, Singhi PD. Infantile Kawasaki disease presenting as acute meningoencephalitis. Int J Rheum Dis [in press] .
    doi: 10.1111/1756-185X.13014pubmed: 28185402google scholar: lookup
  52. Burgner D, Curtis N. Kawasaki disease as a cause of encephalitis. Arch Dis Child 96, 988–9.
    pubmed: 21903602
  53. Husain E, Hoque E. Meningoencephalitis as a presentation of Kawasaki disease. J Child Neurol 21, 1080–1.
    pubmed: 17156704
  54. Stowe RC. Facial nerve palsy, Kawasaki disease, and coronary artery aneurysm. Eur J Paediatr Neurol 19, 607–9.
    pubmed: 26101056
  55. Rawat A, Singh S. Biomarkers for diagnosis of Kawasaki disease. Indian Pediatr 52, 473–4.
    pubmed: 26121719
  56. Parthasarathy P, Agarwal A, Chawla K, Tofighi T, Mondal TK. Upcoming biomarkers for the diagnosis of Kawasaki disease: a review. Clin Biochem 48, 1188–94.
    pubmed: 25749557
  57. Wu L, Chen Y, Zhong S, Li Y, Dai X, Di Y. Blood N‐terminal pro‐brain natriuretic peptide and interleukin‐17 for distinguishing incomplete Kawasaki disease from infectious diseases. Indian Pediatr 52, 477–80.
    pubmed: 26121721
  58. Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK. Pro‐brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. Rheumatol Int 36, 551–9.
    pubmed: 26849890
  59. Lin K‐H, Chang S‐S, Yu C‐W. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta‐analysis. BMJ Open 5, e006703.
    pmc: PMC4401842pubmed: 25872939
  60. Kimura Y, Yanagimachi M, Ino Y. Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis. Sci Rep 7, 43732.
    pmc: PMC5338030pubmed: 28262744
  61. Rong X, Jia L, Hong L. Serum miR‐92a‐3p as a new potential biomarker for diagnosis of Kawasaki disease with coronary artery lesions. J Cardiovasc Transl Res 10 (1), 1–8.
    pubmed: 27981487
  62. Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol 67, 1738–49.
    pubmed: 27056781
  63. Jiao F, Yan X, Wu X. The Xi'an experience of Kawasaki disease ‐ lessons learnt over 5 years. Indian J Pediatr 83, 1195–6.
    pubmed: 27094776
  64. JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)–digest version. Circ J 74, 1989–2020.
    pubmed: 20724794
  65. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Ministry of Health and Welfare, Tokyo, Japan.
  66. Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z‐scores after Kawasaki disease. Pediatr Cardiol 31 (2), 242–9.
    pubmed: 20024653
  67. Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr 24 (1), 60–74.
    pubmed: 21074965
  68. Kobayashi T, Fuse S, Sakamoto N. A new Z score curve of the coronary arterial internal diameter using the lambda‐mu‐sigma method in a pediatric population. J Am Soc Echocardiogr 29, 794–801.e29.
    pubmed: 27288089
  69. Margossian R, Lu M, Minich LL. Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr 24 (1), 53–9.
    pmc: PMC3022385pubmed: 21172596
  70. Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child 100, 1084–8.
    pubmed: 26111818
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.